Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 10/2000

01-10-2000

Activated peritoneal macrophages inhibit the proliferation of rat ascites hepatoma AH-130 cells via the production of tumor necrosis factor-α and nitric oxide

Authors: H. Maekawa, K. Iwabuchi, I. Nagaoka, H. Watanabe, T. Kamano, M. Tsurumaru

Published in: Inflammation Research | Issue 10/2000

Login to get access
Metadata
Title
Activated peritoneal macrophages inhibit the proliferation of rat ascites hepatoma AH-130 cells via the production of tumor necrosis factor-α and nitric oxide
Authors
H. Maekawa
K. Iwabuchi
I. Nagaoka
H. Watanabe
T. Kamano
M. Tsurumaru
Publication date
01-10-2000
Publisher
Birkhäuser Verlag
Published in
Inflammation Research / Issue 10/2000
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s000110050629

Other articles of this Issue 10/2000

Inflammation Research 10/2000 Go to the issue

OriginalPaper

Effects of the non-peptide B2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation

OriginalPaper

Action of dexamethasone in the suppression of delayed-type hypersensitivity in reconstituted SCID mice

OriginalPaper

Immediate inhibition by oral l-ephedrine of passive cutaneous anaphylaxis of rats: indirect inhibition of anaphylactic chemical mediator release from the mast cell

OriginalPaper

Comparison of the effect of imidaprilat and ramiprilat on bronchoconstriction and hypotension induced by bradykinin in guinea pigs

OriginalPaper

Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis

OriginalPaper

Important role of CD18 in TNF-α-induced leukocyte adhesion in muscle and skin venules in vivo
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits